Kymera Therapeutics, Inc. (KYMR)

85.10 -0.17 (-0.20%) USD  |  NASDAQ  |  Apr 07, 16:00
85.17 +0.07 (+0.08%) After-Hours: 20:00
More

Kymera Therapeutics Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Revolution Medicines, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Structure Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade